News
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
Robert F. Kennedy Jr. is targeting a little-known program that underpins childhood immunizations in the U.S. by paying people ...
No sign of macroeconomic impact as 'we haven't seen any change from Q1 to Q2', Publicis CEO Arthur Sadoun says.
Bausch + Lomb’s campaign builds off its survey results to address misconceptions and connect audiences to accurate information.
Whether Kennedy hands down a ban or one is passed on Capitol Hill, pharma marketing is set to undergo a significant transformation.
According to recent findings from Lob’s 2025 State of Direct Mail: Consumer Insight Report, healthcare has emerged as one of the highest performing sectors in the direct mail space. This stems from ...
Patients need to communicate clearly with their healthcare provider. But that’s getting more difficult for those in the U.S.
Jordan-Poinsette becomes head of the North America health sector; Corso takes on the role of EVP and head of We. global health growth and integration.
Inventiva named Jason Campagna as president of R&D and chief medical officer, and Martine Zimmermann as EVP of regulatory affairs and quality assurance. Evolent named Dr. David Lim as chief clinical ...
Novartis made one of the biggest investments in Cannes among pharma companies, sending approximately 20 people from the ...
M Booth has launched Culture Mark, a proprietary AI-powered methodology designed to make it clearer and easier for brands to make their mark in culture and deliver value, the agency said in a ...
Schmuckler joins Real Chemistry after spending nearly 20 years at WPP. Real Chemistry named WPP veteran JJ Schmuckler as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results